Zuojun Zhen

490 total citations
16 papers, 158 citations indexed

About

Zuojun Zhen is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Zuojun Zhen has authored 16 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Zuojun Zhen's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Mechanisms and Therapy (2 papers). Zuojun Zhen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Mechanisms and Therapy (2 papers). Zuojun Zhen collaborates with scholars based in China, Hong Kong and United States. Zuojun Zhen's co-authors include Fengjie Wang, Eric C. H. Lai, Huanwei Chen, Linpei Wang, Wan Yee Lau, Haitao Li, Li Li, Li Li, Jieyuan Li and Yingjun Chen and has published in prestigious journals such as Gene, Medicine and World Journal of Surgery.

In The Last Decade

Zuojun Zhen

16 papers receiving 156 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuojun Zhen China 7 58 55 50 45 36 16 158
Yoshiro Asahina Japan 9 37 0.6× 56 1.0× 45 0.9× 43 1.0× 22 0.6× 18 152
Bernardo Stefanini Italy 7 44 0.8× 85 1.5× 36 0.7× 41 0.9× 31 0.9× 32 172
Wen‐Bin Ding China 6 49 0.8× 67 1.2× 75 1.5× 28 0.6× 51 1.4× 11 199
Anne‐Laure Védié France 6 41 0.7× 34 0.6× 44 0.9× 24 0.5× 27 0.8× 11 153
De‐Zhen Guo China 7 47 0.8× 67 1.2× 34 0.7× 22 0.5× 40 1.1× 25 137
Ken Shirabe Japan 5 42 0.7× 47 0.9× 47 0.9× 75 1.7× 13 0.4× 7 154
Haofeng Lu China 5 29 0.5× 53 1.0× 127 2.5× 29 0.6× 94 2.6× 9 205
Lu Guo China 7 40 0.7× 71 1.3× 44 0.9× 13 0.3× 38 1.1× 12 152
Erik Ramon‐Gil United Kingdom 3 52 0.9× 72 1.3× 17 0.3× 23 0.5× 23 0.6× 5 126

Countries citing papers authored by Zuojun Zhen

Since Specialization
Citations

This map shows the geographic impact of Zuojun Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuojun Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuojun Zhen more than expected).

Fields of papers citing papers by Zuojun Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuojun Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuojun Zhen. The network helps show where Zuojun Zhen may publish in the future.

Co-authorship network of co-authors of Zuojun Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Zuojun Zhen. A scholar is included among the top collaborators of Zuojun Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuojun Zhen. Zuojun Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Li, Li, et al.. (2021). MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma. Cytokine. 141. 155436–155436. 17 indexed citations
4.
6.
Chen, Huanwei, et al.. (2019). Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib. Medicine. 98(18). e14595–e14595. 7 indexed citations
7.
Wang, Linpei, et al.. (2018). CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma. Gene. 690. 129–136. 34 indexed citations
8.
Li, Meisheng, et al.. (2018). Unusual bleeding from hepaticojejunostomy controlled by side-to-side splenorenal shunt. Medicine. 97(32). e11784–e11784. 1 indexed citations
9.
Xiang, Qingfeng, Zuojun Zhen, David Deng, et al.. (2015). Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 118–118. 33 indexed citations
10.
Wang, Fengjie, et al.. (2014). Laparoscopic Right Hemihepatic Vascular Inflow Occlusion by Lowering of the Hilar Plate. Journal of Laparoendoscopic & Advanced Surgical Techniques. 24(12). 833–836. 5 indexed citations
11.
Chen, Huanwei, et al.. (2014). Prognostic impact of hepatic resection for hepatocellular carcinoma: The role of the surgeon in achieving R0 resection – A retrospective cohort study. International Journal of Surgery. 13. 297–301. 13 indexed citations
12.
Zhen, Zuojun, et al.. (2014). Laparoscopic liver resection under hemihepatic vascular inflow occlusion using the lowering of hilar plate approach. Hepatobiliary & pancreatic diseases international. 13(5). 508–512. 11 indexed citations
14.
Lai, Eric C. H., et al.. (2008). Modified Technique of Pancreaticojejunal Anastomosis with Invagination Following Pancreaticoduodenectomy: A Cohort Study. World Journal of Surgery. 32(12). 2695–700. 15 indexed citations
15.
Xu, Zhuoming, et al.. (2006). [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].. PubMed. 26(11). 1626–8. 4 indexed citations
16.
Lin, Fei, et al.. (2004). [Hand-assisted laparoscopic partial hepatectomy in the treatment of primary liver cancer].. PubMed. 24(9). 1084–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026